Catalio Capital

Catalio Capital Management is a venture capital firm founded in 2020 and based in New York, New York. The firm focuses on investing in breakthrough biomedical technology companies and manages several funds, including Catalio Access Fund I and II, Catalio Genesis Fund IV, and Catalio Nexus Fund III, which are based in Baltimore and New York. Catalio Capital also engages in various asset classes, such as private equity, private credit, and public equity, employing a long bias and fundamental investment strategy. Additionally, the firm is a Registered Investment Adviser, indicating its compliance with regulatory standards in managing investment funds.